PRTC
PureTech Health plc
NASDAQ · Healthcare · Biotechnology · US
$17.38
+2.12%Institutional positioning
13F filings over the trailing two quarters
New 0Increased 2Reduced 0Sold out 5
| Filer | Action | Shares | Filed |
|---|---|---|---|
| PENTWATER CAPITAL MANAGEMENT LP | Unchanged | 70,000 | May 15, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 59,525 | May 15, 2026 |
| DIADEMA PARTNERS LP | Increased | 7,924 | May 15, 2026 |
| PERSISTENT ASSET PARTNERS LTD | Unchanged | 1,759 | May 12, 2026 |
| UBS GROUP AG | Unchanged | 20 | May 5, 2026 |
| DIADEMA PARTNERS LP | Sold Out | 0 | May 15, 2026 |
| Persistent Asset Partners Ltd | Sold Out | 0 | May 12, 2026 |
| UBS Group AG | Sold Out | 0 | May 5, 2026 |
| MILLENNIUM MANAGEMENT LLC | Sold Out | 0 | May 15, 2026 |
| Pentwater Capital Management LP | Sold Out | 0 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings